iRhythm Technologies, Inc. (IRTC) NASDAQ
120.66
-4.21(-3.37%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
120.66
-4.21(-3.37%)
Currency In USD
Address
699 8th Street
San Francisco, CA 94103
United States of America (the)
Phone
415 632 5700
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
2000
First IPO Date
October 20, 2016
| Name | Title | Pay | Year Born |
| Quentin S. Blackford | President, Chief Executive Officer & Director | 2.08M | 1979 |
| Daniel G. Wilson | Chief Financial Officer & Principal Financial Officer | 970,199 | 1982 |
| Patrick Michael Murphy | Chief Business & Legal Officer | 987,343 | 1979 |
| Minang Turakhia | Chief Medical & Scientific Officer and Executive Vice President of Advanced Technologies | 1.03M | 1974 |
| Chad Patterson | Chief Commercial and Product Officer | 1.28M | 1982 |
| Brian Lawrence | Executive Vice President & Chief Technology Officer | 0 | 1970 |
| Mervin Smith | Executive Vice President of Business Operations | 0 | 1975 |
| Marc Rosenbaum | Senior Vice President of Finance & Chief Accounting Officer | 0 | 1973 |
| Sumi Shrishrimal | Executive Vice President & Chief Risk Officer | 0 | 1980 |
| Sean Clinton Freeman | Executive Vice President of Strategy & Corporate Development | 0 | 1976 |
| Julie Rodda | Executive VP, Chief People & Capability Officer | 0 | 1981 |
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.